FDA approves Narcan Nasal Spray to treat opioid overdose
19 November 2015 | By Victoria White
Until this approval, naloxone was only approved in injectable forms, most commonly delivered by syringe or auto-injector...
List view / Grid view
News
New long-term data for Opdivo in advanced melanoma announced
19 November 2015 | By Victoria White
In the CheckMate -066 trial, Opdivo continued to demonstrate superior overall survival versus dacarbazine with 57.7% of patients alive at two years compared to 26.7% of patients treated with dacarbazine...
First patient enrolled in trial of amatuximab in mesothelioma
18 November 2015 | By Victoria White
Amatuximab is a monoclonal antibody (mAb) that triggers antibody-dependent cellular cytotoxicity against tumour cells expressing mesothelin...
ECDC survey shows increasing threat of antibiotic resistance
18 November 2015 | By Victoria White
Survey results released by the ECDC show that the situation continues to worsen with regard to the spread of CPE in the EU, with 3 countries reporting an endemic situation...
Pfizer’s Phase 3 Xalkori NSCLC trial meets primary objective
18 November 2015 | By Victoria White
Xalkori demonstrated significantly prolonged progression-free survival in previously untreated East Asian patients with ALK-positive advanced NSCLC...
Portsmouth PMU selects Cherwell for quality and service in environmental monitoring
18 November 2015 | By Cherwell Laboratories
Cherwell publishes case study discussing key considerations when purchasing an active air sampler...
NICE says ‘no’ to Amgen’s Repatha in draft guidance
18 November 2015 | By Victoria White
The NICE Committee felt the question whether Repatha (evolocumab) would reduce angina, heart attacks and strokes remains unanswered...
FDA grants Breakthrough Therapy designation to avelumab for MCC
18 November 2015 | By Victoria White
Avelumab (MSB0010718C) is an investigational fully human anti-PD-L1 IgG1 monoclonal antibody...
Personalised peptide vaccine increased bladder cancer survival in study
18 November 2015 | By Victoria White
The median overall survival for patients assigned personalised peptide vaccine and best-supportive care was almost twice as long as that for patients assigned best-supportive care...
Viking submits IND for VK2809 in hypercholesterolemia
18 November 2015 | By Victoria White
VK2809 is a novel, orally available small molecule thyroid receptor agonist that possesses selectivity for liver tissue as well as the beta receptor subtype...
Merck launches production of its anti-diabetes medicine in Algeria
18 November 2015 | By Victoria White
Merck and Novapharm have announced a joint venture in Algeria to produce Merck’s diabetes and high blood pressure treatments for the Algerian market...
Final call for innovators: Pharmapack Europe Awards 2016
17 November 2015 | By Victoria White
The Pharmapack Europe Awards centralise the latest innovations in packaging and drug delivery, offering a unique view into tomorrow’s developments today...
Global NSCLC treatment market value to rise to $10.9 billion
17 November 2015 | By Victoria White
GBI Research says that the introduction of novel immune-checkpoint inhibitors, such as Opdivo and Keytruda, will drive the market...
FDA approves Darzalex for multiple myeloma
17 November 2015 | By Victoria White
Darzalex (daratumumab) is the first human anti-CD38 monoclonal antibody (mAb) approved anywhere in the world...
Kadcyla ‘price remains too high’, says NICE
17 November 2015 | By Victoria White
NICE has published final draft guidance not recommending the use of Kadcyla as a treatment for a type of advanced breast cancer because the price is too high...
